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Abstract
Numerous lines of evidence support the premise that withholding
and withdrawing life support measures in the intensive care unit
are not the same. These include questionnaires, practical
observations and an examination of national medical guidelines. It
is important to distinguish between the two end of life options as
their outcomes and management are significantly different.
Appreciation of these differences allows the provision of accurate
information, and facilitates decision making that is compassionate,
caring and adherent to the needs of the patient and their family. 
During rounds in the critical care unit a discussion arises
regarding continued antibiotic therapy in a patient who has
not responded. Should antibiotics be added, should the
current therapy be maintained, or should the antibiotics be
stopped? No one would dispute that these options are
different. Replacing the word ‘antibiotics’ with ‘inotropes’,
‘ventilation’, or ‘life support’ does not alter this reality.
Stopping life-support measures (withdrawal of therapy) is not
the same as refraining from starting them (withholding) or
maintaining current therapy. The former is an active measure,
whereas the latter two are passive. Often patients’ families
clearly understand this difference; they ask, ‘Are you just
going to let him [the patient] go doctor, or are you going to
pull the plug?’
An appreciation of the differences between withdrawing and
withholding life-support therapies can also be found in the
medical literature from physician questionnaires and empirical
observations of end-of-life practice. The experience of
withholding as compared to withdrawing therapy has been
examined in two large questionnaire-based surveys, one from
North America and the other from Europe. In the North
American study [1] 26% of physicians reported being more
disturbed at the prospect of withdrawing therapy than they
were about withholding. Similarly, the European survey [2]
showed that more physicians were willing to withhold
treatment in a patient vignette than were willing to withdraw.
In an additional study [3], when directly questioned on the
equivalence of withdrawing and withholding treatments, only
34% of 1446 physicians and nurses saw these two options
as equivalent. These surveys indicate that, regardless of
theoretical equivalence, physicians do not see withholding
and withdrawing as the same.
Practically, a recent large European study [4] highlighted
the differences in effect of withholding and withdrawing
therapy. The circumstances surrounding the deaths of 4248
ICU patients were recorded in this study. Following
withdrawal of therapy 99% of patients died, and death
ensued within a median of 4 hours. In marked contrast,
when therapy was withheld 11% of patients survived,
whereas for those who died death ensued after a median of
14.3 hours (P < 0.001). The interpretation of this study is
limited by its observational nature; the patients for whom
therapy was withheld or withdrawn might not have been
similar. However, this does not detract from the main
finding, namely that withdrawal of therapy is followed by a
near certain and rapid death.
Furthermore, the differences between withholding and
withdrawing can be demonstrated by considering the
extremes. The ‘simplest’ form of withholding therapy is
determined by the do not resuscitate order. Such an order
may be placed in a living will by somebody who is in perfect
health. This patient may not experience any medical
intervention at all for many years. In contrast, once a decision
is made to withdraw therapy, ventilation or inotropes will be
stopped, heavy sedation is usually commenced and death will
typically ensue. These extremes are clearly very different.
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Even guidelines relating to end-of-life care are careful in their
terminology. The American Medical Association guideline [5]
(paragraph 2) states that, ‘there is no ethical distinction
between withdrawing and withholding life sustaining
treatments’, whereas the UK General Medical Council
guideline [6] states (paragraph 19) that, ‘there is no ethical or
legal obligation to provide it [a treatment not in the patient’s
best interest] and therefore no need to make a distinction
between not starting the treatment and withdrawing it’.
Neither guideline states that there is no difference between
withholding and withdrawing therapy, but rather that they are
equal legally and ethically. Indeed, immediately prior to the
statement quoted above, the General Medical Council
guideline describes a clear difference between withholding
and withdrawing therapy, stating that, ‘it may be emotionally
more difficult … to withdraw a treatment … than to decide
not to provide a treatment in the first place.’
What, then, is the importance of distinguishing between
withholding and withdrawing therapy in daily practice? The
principle of patient autonomy determines that the patient or
their proxy should be in possession of relevant information
before determining the appropriate course of action. Given
that there are significant practical differences between
withholding and withdrawing therapy, where appropriate the
patient or proxy may wish to be made aware of the
implications of their decisions. On a more personal level,
end-of-life decisions are always difficult. Good
communication and the reduction in uncertainty probably
help to mitigate these difficulties to some degree. Once a
decision has been made to either withhold or withdraw
therapy, a clear explanation of what the family should
expect, in terms of actions to be taken and the expected
time course of events, might in part reduce uncertainty and
prepare the family for the difficult and final parting from a
loved one.
Having established that there is a difference between
withholding and withdrawing life-sustaining measures at the
end of life, we are unwilling to be drawn into a discussion of
what is better and worse end-of-life care. There is no single
formula for better or worse treatment at the end of life – there
is only good treatment. Good treatment is that which is
compassionate and caring, and adheres to the needs and
requirements of the patients or their families.
Among the physician’s many duties is the obligation to try and
persuade the patient (or their family) to accept the best
treatment available. To enter into an end-of-life discussion
with the preconceived belief that withdrawing is better than
withholding therapy is equivalent to saying that it is the
physician’s duty to convince the ICU patient or their family of
this. This abrogates the basic understanding that, at the end
of life, different strategies are equally right for different
people, based not on APACHE scores, organ failures and
machines, but on culture, upbringing and personal belief. The
application of preconceived beliefs also negates the principle
of patient autonomy at the end of life.
So, to conclude, do not enter into discussions with the ICU
patient or their family with the notion that withdrawal of care
is the only or preferable option. Explain that the situation
appears hopeless, and then listen – listen to what the family
is telling you.
Withdrawing may be preferable to withholding:
response to commentary by Vincent
One of the first arguments Professor Vincent [7] presents is
based on the fallacy of the full ICU. Vincent claims that if
withdrawal of therapy were not to be performed, then the ICU
would be full of hopelessly ill patients maintained indefinitely
on life support. This is not the case. The recent ETHICUS
study [4] showed that the median time to death for patients in
whom therapies were withheld was 14 hours, rather than
4 hours in those whose therapy was withdrawn. This 10 hour
difference is unlikely to differentiate between an ICU that is
full and one with empty beds. In our ICU, and many others, it
frequently takes longer than 10 hours to find a vacant ward
bed for a patient who is ready for ICU discharge.
Furthermore, as the association between intensive care and
expertise in end-of-life care becomes a reality in the hospital
environment, we have been witness to a paradoxical increase
in ICU admissions of the hopelessly ill.
Vincent is also concerned that refusal to withdraw care might
introduce hesitation into the actions of ICU physicians. We
would hope that the ICU physician dealing with an acute life-
threatening situation will concentrate on steps to save lives
rather than consider ICU occupancy statistics. There is
always another bed available, be it in the recovery room,
following discharge of another patient, or in another hospital.
Bed space issues are important but should not be
considered at the expense of life-saving procedures.
Vincent suggests that it is the option for withdrawal of
therapy that allows for the performance of an ‘ICU test’ for
the frail elderly patient with pneumonia and guarded
prognosis. We would argue that if doubt exists regarding the
poor prognosis, then efforts should be made to admit the
patient to ICU care regardless of end-of-life options. After all,
is it right to refuse ICU admission only because that
admission may be prolonged and is not guaranteed to
succeed? Furthermore, in situations of doubt, we would
suggest that within the ICU a ‘withholding test’ has merit. The
ETHICUS study [4] showed that 99% of patients for whom
therapies were withdrawn died, whereas 11% of patients for
whom therapy was withheld survived to hospital discharge.
So, when therapy appears to be failing and the prognosis
looks grim, withholding therapy may be preferable to
withdrawing because it allows for the limitation of potentially
inappropriate therapy while not irrevocably determining
outcome.232
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Finally, our experience of widely accepted withdrawal of
therapy has been the opposite to that presented by Professor
Vincent. Rather than an option that encourages the treatment
of difficult patients whose benefit from ICU admission may be
marginal, the acceptability of withdrawal may lead physicians
and nurses to give up earlier. Statements such as, ‘We all
know that there is no hope; let’s speak to the family about
withdrawal’ are often uttered early in the ICU course, before
all therapeutic options have been explored, and not only in
the frail and elderly. In fact, the ability to predict which
individual patient will survive severe illness is far from perfect.
Furthermore, the willingness of patients who have recovered
from ICU admission to undergo ICU care again, including the
associated suffering, and even for very short periods of
survival [8] cannot be ignored. One wonders indeed whether
the frequent enthusiasm for withdrawal of therapy does not
more reflect the difficulties and fears of the ICU care team
when exposed to the severely injured or chronically ill ICU
patient, rather than their concern for the suffering of the
patients themselves.
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